Cancer-associated fibroblasts and extracellular matrix remodeling in pediatric neuroblastoma
小儿神经母细胞瘤中癌症相关成纤维细胞和细胞外基质重塑
基本信息
- 批准号:10538037
- 负责人:
- 金额:$ 4.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:ADAMTSADAMTS1 geneAdrenal GlandsAdrenal NeuroblastomaAdultAffectAttentionAutomobile DrivingCD4 Positive T LymphocytesCancer BiologyCellsCessation of lifeChemicalsChildChildhoodChildhood Solid NeoplasmChromiumCoculture TechniquesCollagenConfocal MicroscopyCytokine GeneDataDepositionDevelopmentDiseaseEnterobacteria phage P1 Cre recombinaseEnzymesEtiologyEvolutionExtracellular MatrixFibroblastsFlow CytometryGene DeletionGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGenetic TranscriptionHeterogeneityImmuneImmune signalingImmune systemImmunocompetentImmunofluorescence ImmunologicImmunofluorescence MicroscopyImmunologicsIncidenceInfiltrationInflammationInvestigationLaboratoriesLaboratory StudyLamininLocationMYCN geneMalignant Childhood NeoplasmMalignant NeoplasmsMapsMediatingModelingMolecularMonitorMusMyeloid CellsNeoplasm MetastasisNeuroblastomaNeuroendocrine CellPatientsPhenotypeProcessProgressive DiseaseProteinsProteoglycanProteolysisRag1 MouseResectedRoleSignal TransductionSiteSmooth Muscle Actin Staining MethodSolidSolid NeoplasmStatistical Data InterpretationStromal CellsSurvival RateT-LymphocyteTestingTissue-Specific Gene ExpressionTumor VolumeWT1 geneangiogenesisanti-tumor immune responsebasecancer cellcell typechemokinecrosslinkcytokineexperimental studyhigh riskimprovedin vivoinsightlymphocyte traffickingmacrophagepatient subsetspremalignantpreventrecruitsingle cell analysistranscriptomicstumortumor growthtumor microenvironmenttumor progressiontumor-immune system interactionstumorigenesistumorigenicversican
项目摘要
PROJECT SUMMARY
Extracellular matrix (ECM) remodeling is a critical process within the solid tumor microenvironment. Cancer-
associated fibroblasts (CAFs) are the primary producers of matrix proteins and remodeling enzymes that cross-
link and degrade matrix proteins. CAFs are enigmatic in that they can promote or impede tumor growth,
suggesting heterogeneity that is not completely understood. How CAF heterogeneity evolves over tumor
progression and how this evolution impacts ECM remodeling within solid tumors remain an outstanding question
in cancer biology. Recent studies have focused on CAF function in models of adult cancer, but little attention
has been directed toward understanding CAF heterogeneity and ECM remodeling in childhood cancers, which
are etiologically different diseases.
Neuroblastoma (NB) is a childhood cancer of neuroendocrine cells that accounts for 15% of pediatric cancer
deaths. The 5-year overall survival rate for high-risk NB remains at 50%, highlighting the need for a deeper
understanding of the molecular and immunological mechanisms driving tumorigenesis in this subset of patients.
Like other solid tumors, the NB tumor microenvironment includes malignant cells, CAFs, and immune cells. Our
laboratory studies NB using a penetrant, spontaneous model of high-risk NB (TH-MYCN, AlkF1178L/+) in
immunocompetent mice, allowing in vivo investigation of the tumor immune microenvironment from
tumorigenesis to progressive disease. Using this model, we previously demonstrated the pro-tumorigenic role of
macrophages and CD4+ T cells by showing that their depletion significantly reduced the formation of tumors and
extended survival.
My preliminary experiments utilizing 10X Chromium gene expression analysis of stromal cells from nascent and
mature tumors identified two distinct subsets of CAFs characterized by alpha smooth muscle actin (Acta2) and
Wilms tumor 1 (Wt1) expression. Interestingly, only Wt1 CAFs expressed chemokines and cytokines involved in
recruitment of myeloid and T cells. Wt1 CAFs were enriched in the early tumor microenvironment and expressed
genes encoding ADAMTS enzymes involved in degradation of the proteoglycan versican. Our preliminary
findings indicate that Wt1 CAFs may be a crucial early recruiter of pro-tumorigenic immune cells in our model of
neuroblastoma. The studies proposed will assess how CAF heterogeneity affects ECM remodeling over
neuroblastoma progression, examine tumor-CAF and CAF-immune signaling, and test the effect of perturbing
ECM deposition and degradation on tumor formation and progression. Together, these studies will generate new
and exciting information about the tumor microenvironment and potential vulnerabilities to exploit in pediatric
solid tumors.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicolas Peterson其他文献
Nicolas Peterson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicolas Peterson', 18)}}的其他基金
Cancer-associated fibroblasts and extracellular matrix remodeling in pediatric neuroblastoma
小儿神经母细胞瘤中癌症相关成纤维细胞和细胞外基质重塑
- 批准号:
10701757 - 财政年份:2022
- 资助金额:
$ 4.28万 - 项目类别: